1. Shanthanagouda AH, Guo B-S, Ye RR, Chao L, Chiang MWL, …, Zhang G (Corresponding Author) and Doris W. T. Au (Corresponding Author). Japanese Medaka: A Non-Mammalian Vertebrate Model for Studying Sex and Age-Related Bone Metabolism In Vivo. PLoS ONE 2014; 9(2): e88165. doi:10.1371/journal.pone.0088165

 

2. Guo B, Zhang B, Zheng L, Tang T, Liu J, Wu H, Yang Z, Peng S, He X, Zhang H, Yue KK, He F, Zhang L, Qin L, Bian Z, Tan W, Liang Z, Lu A, Zhang G (Corresponding Author). Therapeutic RNA interference targeting CKIP-1 with a cross-species sequence to stimulate bone formation. Bone 2014; 59:76-88

 

3. Wang S, Wei X, Zhou J, Zhang J, Li K, Chen Q, Terek R, Fleming BC, Goldring MB, Ehrlich MG, Zhang G, Wei L. Identification of Alpha 2 Macroglobulin (A2M) as a master inhibitor of cartilage degrading factors that attenuates post-traumatic osteoarthritis progression. Arthritis Rheumatol. 2014 Feb 27

 

4. Xiaogang Wang, Baosheng Guo, Qi Li, Jiang Peng, Zhijun Yang, Aiyuan Wang, Dong Li, Zhibo Hou, Ke Lv, Guanghan Kan, Hongqing Cao, Heng Wu, Jinping Song, Xiaohua Pan, Qiao Sun, Shukuan Ling, Yuheng Li, Mu Zhu, Pengfei Zhang, Songlin Peng, Xiaoqing Xie, Tao Tang, An Hong, Zhaoxiang Bian, Yanqiang Bai, Aiping Lu, Yinghui Li, Fuchu He, Ge Zhang (Corresponding Author), Yingxian Li (Corresponding Author). miR-214 targets ATF4 to inhibit bone formation. Nature Medicine 2013;19:93-100

 

5. Zhang G (Corresponding Author), Guo BS, Wu H, Tang T, Zhang BT, et al. A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy. Nature Medicine 2012; 18(2):307-14 

 

6. Zhu HM, Qin L, Garnero P, Genant HK, Zhang G (Co-first Author), Dai K, Yao X, Gu G, Hao Y, Li Z, Zhao Y, Li W, Yang J, Zhao X, Shi D, Fuerst T, Lu Y, Li H, Zhang X, Li C, Zhao J, Wu Q, Zhao SJ. The first multi-center and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis. Osteoporosis Int. 2012; 23:1317-27

 

7. Zhang G, Qin L, Shi Y. Epimedium-Derived Phytoestrogen Flavonoids Exert Beneficial Effect on Preventing Bone Loss in Late Postmenopausal Women: A 24-Month Randomized, Double-Blind and Placebo-Controlled Trial. Journal of Bone and Mineral Research 2007; 22: 1072-1079

 

8. Sheng H, Zhang G, Cheung WH, Chan CW, Wang YX, Lee KM, Wang HF, Leung KS, Qin LL. Elevated adipogenesis of marrow mesenchymal stem cells during early steroid-associated osteonecrosis development. J Orthop Surg. 2007; 2:15.

 

9. Qin L, Zhang G, Sheng H, Wang XL, Wang YX, Yeung KW, JF. Griffith, Li ZR, Leung KS, Yao XS. Phytoestrogenic compounds for prevention of steroid-associated osteonecrosis. J Musculoskelet Neuronal Interact 2008; 8

 

10. Qin L, Zhang G, Leung KS. Once-monthly Ibandronate: A Convenient Dosing Regimen Established for Postmenopausal Osteoporosis. Medical Progress (http://www.medicalprogress.com/) 2007; 34: 188-192

 

11. Qin L, Zhang G. Strontium Ranelate: An Anti-osteoporotic Agent with dual action mechanism. Medical Progress (http://www.medicalprogress.com/). 2006; 33: 447-450

 

12. Song XS, Zhou XZ, Zhang G, et al. Low-dose X-ray irradiation promotes fracture healing through up-regulation of vascular endothelial growth factor. Med Hypotheses. 2010;75:522-4

 

13. Zhang G, Sheng H, He YX, et al. Continuous occurrence of both insufficient neovascularization and elevated vascular permeability during inadequate repair of steroid-associated osteonecrotic lesions. Arthritis & Rheumatism 2009; 60: 2966-77

 

 


Copyright © 2015 Hong Kong Chinese Medicine Clinical Study Centre